Association of use of Chinese herbal medicines and the risk of fracture in patients with osteoporosis: a population-based cohort study
After utilizing a large population-based claims database and the application of propensity score match approach to reduce the confounding effects, we found that the use of Chinese herbal medicines (CHMs) was related to the lower risk of sequent osteoporotic fracture by 27% among the individuals with osteoporosis. The predominant effect was observed in those receiving CHMs for more than two years.
Osteoporosis (OS) is a highly disabling condition that can lead to fragility fracture, thus posing greater burdens of functional limitations for the affected individuals. It is unclear if the use of Chinese herbal medicines (CHMs) could reduce the risk of fracture due to OS. This study aimed to investigate the association of CHMs and the subsequent osteoporotic fracture risk among OS patients.
This longitudinal cohort study used the Taiwanese National Health Insurance Research Database to identify 250,699 newly diagnosed OS patients aged 20 years or older between 1998 and 2010. We recruited 103,325 CHM users following the onset of OS (CHM users) and randomly selected 103,325 subjects without CHM usage as controls (non-CHM users) by propensity score matching according to the demographic characteristics and comorbidities at enrollment. All enrollees were followed until the end of 2012 to record the incidence of osteoporotic fracture. We applied the Cox proportional hazard regression model to compute the hazard ratio (HR) of the risk of osteoporotic fracture.
During the 15-year follow-up period, 7208 CHM users and 11,453 non-CHM users sustained osteoporotic fracture, with an incidence rate of 9.26 and 12.96, respectively, per 1000 person-years. We found that CHM users had a significantly reduced risk of osteoporotic fracture compared to non-CHM users (adjusted HR 0.73; 95% confidence interval [CI] = 0.70–0.75). Those treated with CHMs for longer than 730 days had a lower fracture risk by 54%. Some commonly used CHMs, such as Yan hu suo (Rhizoma Corydalis), Huang Qin (Scutellaria Baicale), Jie Geng (Platycodon grandifloras), Xiang Fu (Cyperus rotundus), Hai Piao Xiao (Cuttlebone Sepium), Jia-Wei-Xiao-Yao-San, Ge-Gen-Tang, Shao-Yao-Gan-Cao-Tang, and Du-Huo-Ji-Sheng-Tang, are related to the lower risk of fracture.
The use of CHMs was associated with lower risk of osteoporotic fracture for OS patients, suggesting that it could be integrated into conventional therapy to prevent subsequent bone fracture.
KeywordsChinese herbal medicines Cohort study Osteoporosis Osteoporotic fracture
This study is based in part on data from the National Health Insurance Research Database provided by the Bureau of National Health Insurance, Department of Health, and managed by the National Health Research Institutes. The interpretation and conclusions contained herein do not represent those of the Bureau of National Health Insurance, Department of Health, or National Health Research Institutes. This research was supported by the Dalin Tzuchi Hospital (Grant DTCRD101-E-08).
Compliance with ethical standards
Conflicts of interest
Chen WJ, Livneh H, Hsieh MH, Yeh CC, Yeh MH, Lu MC, Chien JT, and Tsai TY declare that they have no conflict of interest.
- 1.Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jöhnsson B, Kanis JA (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8:136PubMedPubMedCentralCrossRefGoogle Scholar
- 2.Nelson HD, Morris CD, Kraemer DF, Mahon S, Carney N, Nygren PM, Helfand M (2001) Osteoporosis in postmenopausal women: diagnosis and monitoring. Evid Rep Technol Assess 28:1–2Google Scholar
- 3.International Osteoporosis Foundation. Facts and statistics (2017) https://www.iofbonehealth.org/facts-statistics. Accessed 4 Feb 2017
- 14.Ren YB, Huang JH, Cai WJ, Shen ZY (2015) Shen-Jing as a Chinese medicine concept might be a counterpart of stem cells in regenerative medicine. Chin J Integr Med Epub ahead printGoogle Scholar
- 17.Liu Y, Liu JP, Xia Y (2014) Chinese herbal medicines for treating osteoporosis. Cochrane Database Syst Rev 3:CD005467Google Scholar
- 21.Liu CY, Hung YT, Chuang YL, Chen YJ, Weng WS, Liu JS, Liang KY (2006) Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manag 4(1):1–22Google Scholar
- 27.Lee SC, Wu SH, Hsiao TH, Yang YC, Tien YC (2005) Effects of Chia-wei-hsiao-yao-san on bone loss in ovariectomized rats. J Food Drug Anal 13(3):232–238Google Scholar
- 31.Ji M, Liu Y, Yang S, Zhai D, Zhang D, Bai L, Wang Z, Yu J, Yu C, Cai Z (2013) Puerarin suppresses proliferation of endometriotic stromal cells in part via differential recruitment of nuclear receptor coregulators to estrogen receptor-α. J Steroid Biochem Mol Biol 138:421–426PubMedCrossRefGoogle Scholar
- 32.Chen G, Jia P, Gao X (2012) Effect and mechanism of shao-yao gan-cao tang on adjuvant-induced arthritis in rats. Afr J Pharm Pharmacol 6(22):1611–1616Google Scholar
- 35.Kum CJ, Kim EY, Kim JH, Lee B, Min JH, Heo J, Kim JH, Yeom M, Sohn Y, Jung HS (2017) Cyperus rotundus L extract suppresses RANKL-induced osteoclastogenesis through NFATc1/c-fos downregulation and prevent bone loss in OVX-induced osteoporosis rat. J Ethnopharmacol 205:186–194PubMedCrossRefGoogle Scholar